Protein family
Protein sequence
Protein function
Catalytic activity
EC number
EC number description
3.4.21.108
Hydrolases;
Acting on peptide bonds (peptidases);
Serine endopeptidases;
HtrA2 peptidase
| PDB | Resolution (Å) | PDB name |
|---|---|---|
| 1LCY | 2.0 | Crystal Structure of the Mitochondrial Serine Protease HtrA2 |
| 2PZD | 2.75 | Crystal Structure of the HtrA2/Omi PDZ Domain Bound to a Phage-Derived Ligand (WTMFWV) |
| 5FHT | 1.95 | HtrA2 protease mutant V226K |
| 5M3N | 1.649 | HTRA2 wild-type structure |
| 5M3O | 1.7 | HTRA2 A141S mutant structure |
| 5TNY | 1.7 | HTRA2 G399S mutant |
| 5TNZ | 1.75 | HtrA2 S142D mutant |
| 5TO0 | 1.9 | HTRA2 S276C mutant |
| 5TO1 | 1.69 | HtrA2 exposed (L266R, F303A) mutant |
| 5WYN | 2.05 | HtrA2 Pathogenic Mutant |
| 7VGE | 4.0 | Structure of the PDZ deleted variant of HtrA2 protease (S306A) |
| 8AUK | 6.2 | Cryo-EM structure of human BIRC6 in complex with HTRA2. |
| 8E2K | 3.21 | Cryo-EM structure of BIRC6/HtrA2-S306A |
| GO ontology
|
GO term | GO description |
|---|---|---|
| Biological Process | GO:0007628 | adult walking behavior |
| Biological Process | GO:0007568 | aging |
| Biological Process | GO:0071363 | cellular response to growth factor stimulus |
| Biological Process | GO:0034605 | cellular response to heat |
| Biological Process | GO:0035458 | cellular response to interferon-beta |
| Biological Process | GO:0034599 | cellular response to oxidative stress |
| Biological Process | GO:0071300 | cellular response to retinoic acid |
| Biological Process | GO:0006672 | ceramide metabolic process |
| Biological Process | GO:0097194 | execution phase of apoptosis |
| Biological Process | GO:0030900 | forebrain development |
| Biological Process | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage |
| Biological Process | GO:0007005 | mitochondrion organization |
| Biological Process | GO:0045786 | negative regulation of cell cycle |
| Biological Process | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization |
| Biological Process | GO:1901215 | negative regulation of neuron death |
| Biological Process | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| Biological Process | GO:0048666 | neuron development |
| Biological Process | GO:0019742 | pentacyclic triterpenoid metabolic process |
| Biological Process | GO:0043065 | positive regulation of apoptotic process |
| Biological Process | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| Biological Process | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| Biological Process | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| Biological Process | GO:0010822 | positive regulation of mitochondrion organization |
| Biological Process | GO:1903955 | positive regulation of protein targeting to mitochondrion |
| Biological Process | GO:0012501 | programmed cell death |
| Biological Process | GO:0016540 | protein autoprocessing |
| Biological Process | GO:0030163 | protein catabolic process |
| Biological Process | GO:0006508 | proteolysis |
| Biological Process | GO:1903146 | regulation of autophagy of mitochondrion |
| Biological Process | GO:0040014 | regulation of multicellular organism growth |
| Biological Process | GO:0009635 | response to herbicide |
| Molecular Function | GO:0042802 | identical protein binding |
| Molecular Function | GO:0008233 | peptidase activity |
| Molecular Function | GO:0004252 | serine-type endopeptidase activity |
| Molecular Function | GO:0008236 | serine-type peptidase activity |
| Molecular Function | GO:0051082 | unfolded protein binding |
| Cellular Component | GO:0035631 | CD40 receptor complex |
| Cellular Component | GO:0000785 | chromatin |
| Cellular Component | GO:0009898 | cytoplasmic side of plasma membrane |
| Cellular Component | GO:0005856 | cytoskeleton |
| Cellular Component | GO:0005829 | cytosol |
| Cellular Component | GO:0005783 | endoplasmic reticulum |
| Cellular Component | GO:0005789 | endoplasmic reticulum membrane |
| Cellular Component | GO:0016020 | membrane |
| Cellular Component | GO:0005758 | mitochondrial intermembrane space |
| Cellular Component | GO:0031966 | mitochondrial membrane |
| Cellular Component | GO:0005739 | mitochondrion |
| Cellular Component | GO:0005634 | nucleus |
| Cellular Component | GO:1905370 | serine-type endopeptidase complex |
| Location
|
ECO term
|
Pubmed |
|---|---|---|
| Endoplasmic reticulum | ECO:0000269 | PubMed:10644717 |
| Mitochondrion intermembrane space | ||
| Mitochondrion membrane | ECO:0000305 |
| HPO ID
|
HPO name |
|---|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000407 | Sensorineural hearing impairment |
| HP:0000518 | Cataract |
| HP:0000551 | Color vision defect |
| HP:0000651 | Diplopia |
| HP:0000713 | Agitation |
| HP:0000716 | Depression |
| HP:0000726 | Dementia |
| HP:0000727 | Frontal lobe dementia |
| HP:0000735 | Impaired social interactions |
| HP:0000736 | Short attention span |
| HP:0000738 | Hallucinations |
| HP:0000739 | Anxiety |
| HP:0000741 | Apathy |
| HP:0000952 | Jaundice |
| HP:0001250 | Seizure |
| HP:0001252 | Hypotonia |
| HP:0001257 | Spasticity |
| HP:0001276 | Hypertonia |
| HP:0001290 | Generalized hypotonia |
| HP:0001332 | Dystonia |
| HP:0001337 | Tremor |
| HP:0001347 | Hyperreflexia |
| HP:0001508 | Failure to thrive |
| HP:0001510 | Growth delay |
| HP:0001522 | Death in infancy |
| HP:0001643 | Patent ductus arteriosus |
| HP:0001662 | Bradycardia |
| HP:0001875 | Neutropenia |
| HP:0001998 | Neonatal hypoglycemia |
| HP:0002014 | Diarrhea |
| HP:0002015 | Dysphagia |
| HP:0002018 | Nausea |
| HP:0002019 | Constipation |
| HP:0002033 | Poor suck |
| HP:0002059 | Cerebral atrophy |
| HP:0002063 | Rigidity |
| HP:0002067 | Bradykinesia |
| HP:0002079 | Hypoplasia of the corpus callosum |
| HP:0002104 | Apnea |
| HP:0002119 | Ventriculomegaly |
| HP:0002141 | Gait imbalance |
| HP:0002151 | Increased serum lactate |
| HP:0002169 | Clonus |
| HP:0002172 | Postural instability |
| HP:0002490 | Increased CSF lactate |
| HP:0002548 | Parkinsonism with favorable response to dopaminergic medication |
| HP:0002578 | Gastroparesis |
| HP:0002878 | Respiratory failure |
| HP:0003344 | 3-Methylglutaric aciduria |
| HP:0003394 | Muscle spasm |
| HP:0003535 | 3-Methylglutaconic aciduria |
| HP:0003623 | Neonatal onset |
| HP:0003811 | Neonatal death |
| HP:0004409 | Hyposmia |
| HP:0005484 | Secondary microcephaly |
| HP:0005943 | Respiratory arrest |
| HP:0011968 | Feeding difficulties |
| HP:0012332 | Abnormal autonomic nervous system physiology |
| HP:0012452 | Restless legs |
| HP:0012707 | Elevated brain lactate level by MRS |
| HP:0025269 | Panic attack |
| HP:0030014 | Female sexual dysfunction |
| HP:0040213 | Hypopnea |
| HP:0040307 | Male sexual dysfunction |
| HP:0100543 | Cognitive impairment |
| HP:0100660 | Dyskinesia |
| HP:0100710 | Impulsivity |
| HP:0100785 | Insomnia |
| Disease name | MONDO ID
|
ICD10
|
ICD10 chapter
|
OMIM
|
Orphanet
|
|---|---|---|---|---|---|
| parkinson disease 13- autosomal dominant- susceptibility to | MONDO:0012466 | G20 | chapter6, Diseases of the nervous system | OMIM:610297 | |
| 3-methylglutaconic aciduria type 8 | MONDO:0044723 | E71 | chapter4, Endocrine, nutritional and metabolic diseases | OMIM:617248 | Orphanet:505208 |